Collaborative Practice Agreement · PharmD
Delaware Collaborative Pharmacy Practice Agreement for Pharmacists
Required. The Collaborative Pharmacy Practice Agreement is the written instrument Delaware law names for a Pharmacist working with a physician. Below: the board that governs it, what it must contain, and the terms it has to carry.
Represents Delaware's 'Collaborative Pharmacy Practice' tier (enacted 2023, Delaware the 50th state to authorize it), not ordinary licensure — base dispensing needs no agreement and is out of scope here. No independence pathway away from the collaborative pharmacy practice agreement (CPPA) was found.
What a Delaware Collaborative Pharmacy Practice Agreement must contain
Governed by the Delaware Board of Pharmacy. Each numbered item is a statutory requirement the agreement must satisfy.
The Pharmacist may provide patient care and drug therapy management services not otherwise permitted to a pharmacist by general licensure only pursuant to a written and signed collaborative pharmacy practice agreement with the Physician, as defined by 24 Del. C. § 2502. The agreement shall define the nature, scope, conditions, and limitations of the services the Pharmacist may provide.
Source: 24 Del. C. § 2502
Delaware law does not require a pharmacist to enter into a collaborative pharmacy practice agreement in order to hold a pharmacist license or dispense medications generally; the agreement described in this Agreement is required only for the expanded patient care and drug therapy management services described above.
- The Collaborative Pharmacy Practice Agreement on file also carries 1 registration clauses, generated in the document itself.
Statutes and rules cited
- 24 Del. C. § 2502statute
Defines 'collaborative pharmacy practice' and 'collaborative pharmacy practice agreement.'
- 24 Del. C. § 1771statute
Limits a collaborating physician to concurrently collaborating with no more than four Physician Assistants absent a Board exemption.
Terms it has to carry
Ratio, proximity, chart review, meeting and prescribing terms the agreement has to carry, from the state's supervision rules.
Proximity
Not codified — left to the agreement
Supervision ratio
Not codified — no cap on file
Chart review
Not codified — left to the agreement
Meeting cadence
Not codified — left to the agreement
Prescriptive authority
Covered by the practice agreement · controlled substances permitted
The collaborative pharmacy practice agreement defines the nature, scope, conditions, and limitations of drug-therapy-management services the pharmacist may provide; whether/how controlled substances are scheduled-restricted within that scope wasn't separately confirmed in this research pass — treat as uncertain.
Written agreement
Required
Practice ownership (corporate practice of medicine)
Non-licensee ownership permitted — A pharmacy permit may be held by a non-pharmacist/artificial entity only if a majority of the pharmacy is owned by licensed pharmacists; existing permit holders and hospital pharmacies are grandfathered/exempted from the requirement (24 Del.C. Title 24 Ch. 25, Subch. IV).
Materially more permissive than the nursing/PA professional-corporation regime above, but not unrestricted — a pharmacist-majority stake is required for new permits.
Legal sources for these rules (2)
About Delaware's rules
Delaware grants full independent practice to APRNs (NP/CRNA/CNM/CNS) after a uniform 2-year/4,000-hour transition period (24 Del.C. § 1906(20); 24 DE Admin. Code 1900 § 8.0) — this research pass treats that rule as applying identically across all four APRN roles; confirm role-specific nuance with the Board of Nursing before relying on it. PAs have no independent-practice pathway.
Other clinicians in Delaware: see the state overview.